DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $127,870,751 | +9.7% | 515,400 | +6.1% | 0.74% | +23.3% |
Q2 2023 | $116,616,491 | -19.6% | 485,902 | -15.6% | 0.60% | -23.2% |
Q1 2023 | $145,040,462 | -38.7% | 575,466 | -35.4% | 0.78% | -39.5% |
Q4 2022 | $236,503,830 | -22.7% | 891,055 | -24.8% | 1.28% | -17.3% |
Q3 2022 | $306,071,000 | +13.6% | 1,184,988 | +11.5% | 1.55% | +23.3% |
Q2 2022 | $269,474,000 | -13.4% | 1,062,929 | +0.2% | 1.26% | +26.6% |
Q1 2022 | $311,206,000 | -39.3% | 1,060,943 | -31.9% | 0.99% | -22.6% |
Q4 2021 | $512,730,000 | +5.3% | 1,558,401 | -2.6% | 1.28% | +10.6% |
Q3 2021 | $487,027,000 | -1.2% | 1,599,748 | -12.9% | 1.16% | -0.2% |
Q2 2021 | $492,856,000 | +5.2% | 1,836,548 | -11.8% | 1.16% | -5.1% |
Q1 2021 | $468,545,000 | -14.4% | 2,081,681 | -15.5% | 1.23% | -13.9% |
Q4 2020 | $547,422,000 | -21.7% | 2,464,311 | -24.1% | 1.42% | -29.8% |
Q3 2020 | $698,707,000 | +4.7% | 3,244,818 | -14.0% | 2.03% | -7.8% |
Q2 2020 | $667,565,000 | -31.3% | 3,775,179 | -46.2% | 2.20% | +3.0% |
Q1 2020 | $971,094,000 | +88.7% | 7,016,072 | +109.3% | 2.14% | +12.7% |
Q4 2019 | $514,600,000 | +14.6% | 3,352,880 | +7.8% | 1.89% | +7.5% |
Q3 2019 | $449,014,000 | -9.3% | 3,108,868 | -10.3% | 1.76% | -7.4% |
Q2 2019 | $495,278,000 | -5.9% | 3,465,419 | -13.1% | 1.90% | -9.3% |
Q1 2019 | $526,420,000 | +90.5% | 3,987,425 | +48.8% | 2.10% | +64.9% |
Q4 2018 | $276,361,000 | -12.1% | 2,679,991 | -7.4% | 1.27% | +7.7% |
Q3 2018 | $314,550,000 | +15.9% | 2,894,814 | +5.3% | 1.18% | +3.7% |
Q2 2018 | $271,334,000 | +7.9% | 2,749,640 | +7.1% | 1.14% | -2.6% |
Q1 2018 | $251,480,000 | +5.8% | 2,568,486 | +0.3% | 1.17% | +8.9% |
Q4 2017 | $237,643,000 | +37.0% | 2,560,259 | +26.6% | 1.07% | +32.3% |
Q3 2017 | $173,482,000 | +20.7% | 2,022,407 | +18.7% | 0.81% | +18.2% |
Q2 2017 | $143,726,000 | -1.5% | 1,703,114 | -0.2% | 0.69% | -5.6% |
Q1 2017 | $145,980,000 | +14.5% | 1,706,766 | +4.2% | 0.73% | +4.9% |
Q4 2016 | $127,452,000 | +671.4% | 1,637,360 | +676.9% | 0.69% | +715.3% |
Q3 2016 | $16,522,000 | +101.5% | 210,761 | +159.7% | 0.08% | +97.7% |
Q2 2016 | $8,198,000 | -52.5% | 81,170 | -55.4% | 0.04% | -50.6% |
Q1 2016 | $17,260,000 | -68.8% | 181,951 | -69.5% | 0.09% | -67.7% |
Q4 2015 | $55,344,000 | -64.6% | 595,865 | -67.5% | 0.27% | -68.4% |
Q3 2015 | $156,139,000 | -22.0% | 1,832,401 | -21.6% | 0.85% | -5.4% |
Q2 2015 | $200,135,000 | +41.8% | 2,338,295 | +40.6% | 0.90% | +41.7% |
Q1 2015 | $141,160,000 | +2.9% | 1,662,664 | +3.8% | 0.64% | -3.8% |
Q4 2014 | $137,248,000 | -2.5% | 1,601,315 | -13.5% | 0.66% | -3.4% |
Q3 2014 | $140,698,000 | -28.7% | 1,851,772 | -26.1% | 0.68% | -29.6% |
Q2 2014 | $197,219,000 | +72.9% | 2,505,004 | +64.7% | 0.97% | +71.9% |
Q1 2014 | $114,083,000 | -14.5% | 1,521,105 | -12.0% | 0.56% | -16.9% |
Q4 2013 | $133,386,000 | +83.8% | 1,727,790 | +65.0% | 0.68% | +68.3% |
Q3 2013 | $72,572,000 | +551.7% | 1,046,920 | +495.1% | 0.40% | +512.1% |
Q2 2013 | $11,136,000 | – | 175,923 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |